Published EBV epitopes restricted by donor HLA class I antigens
| HLA restriction . | Epitope coordinates . | Epitope sequence . | EBV antigen . | Reference No. . |
|---|---|---|---|---|
| A2 | 42-51 | DPTLIPLTIF | EBNA-2 | 50 |
| 596-604 | SVRDRLARL | EBNA-3A | 31 | |
| 284-293 | LLDFVRFMGV | EBNA-3C | 51 | |
| 426-434 | CLGGLLTMV | LMP2 | 52 | |
| 329-337 | LLWTLVVLL | LMP2 | 26 | |
| A11 | 101-115 | NPTQAPVIQLVHAVY | EBNA-3B | 28 |
| 399-408 | AVFDRKSDAK | EBNA-3B | 28 | |
| 416-424 | IVTDFSVIK | EBNA-3B | 28 | |
| 481-495 | LPGPQVTAVLLHEES | EBNA-3B | 28 | |
| 551-563 | DEPASTEPVHDQLL | EBNA-3B | 28 | |
| 340-350 | SSCSSCPLSKI | LMP2 | 26 | |
| B7 | 379-387 | RPPIFIRRL | EBNA-3A | 29 |
| 502-510 | VPAPAGPIV | EBNA-3A | 17 | |
| 881-889 | QPRAPIRPI | EBNA-3C | 29 | |
| B60 | 200-208 | IEDPPFNSL | LMP2 | 26 |
| HLA restriction . | Epitope coordinates . | Epitope sequence . | EBV antigen . | Reference No. . |
|---|---|---|---|---|
| A2 | 42-51 | DPTLIPLTIF | EBNA-2 | 50 |
| 596-604 | SVRDRLARL | EBNA-3A | 31 | |
| 284-293 | LLDFVRFMGV | EBNA-3C | 51 | |
| 426-434 | CLGGLLTMV | LMP2 | 52 | |
| 329-337 | LLWTLVVLL | LMP2 | 26 | |
| A11 | 101-115 | NPTQAPVIQLVHAVY | EBNA-3B | 28 |
| 399-408 | AVFDRKSDAK | EBNA-3B | 28 | |
| 416-424 | IVTDFSVIK | EBNA-3B | 28 | |
| 481-495 | LPGPQVTAVLLHEES | EBNA-3B | 28 | |
| 551-563 | DEPASTEPVHDQLL | EBNA-3B | 28 | |
| 340-350 | SSCSSCPLSKI | LMP2 | 26 | |
| B7 | 379-387 | RPPIFIRRL | EBNA-3A | 29 |
| 502-510 | VPAPAGPIV | EBNA-3A | 17 | |
| 881-889 | QPRAPIRPI | EBNA-3C | 29 | |
| B60 | 200-208 | IEDPPFNSL | LMP2 | 26 |